Urohealth Systems will take over Imagyn Medical in a stock deal which values Imagyn at about $70 million. The deal will add micro-invasive systems to diagnose and treat gynaecological and reproductive disorders to Urohealth's products in urology and general surgery.
The acquisition is Urohealth's third this year